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Abstract
Amphiphysin I, known as a major dynamin-binding partner localized on the collars of nascent
vesicles, plays a key role in clathrin-mediated endocytosis (CME) of synaptic vesicles. Am-
phiphysin I mediates the invagination and fission steps of synaptic vesicles by sensing or facil-
itating membrane curvature and stimulating the GTPase activity of dynamin. Amphiphysin I may
form a homodimer by itself or a heterodimer with amphiphysin II in vivo. Both amphiphysin
I and II function as multilinker proteins in the clathrin-coated complex. Under normal physio-
logical conditions, the functions of amphiphysin I and some other endocytic proteins are known
to be regulated by phosphorylation and dephosphorylation. During hyperexcited conditions, the
most recent data showed that amphiphysin I is truncated by the ca2-dependent protease calpain.
Overexpression of the truncated form of amphi-physin I inhibited transferrin uptake and synaptic
vesicle endocytosis (SVE). This suggests that amphi-physin I may be an important regulator for
SVE when massive amounts of Ca2 flow into presynaptic terminals, a phenomenon observed in
neurodegenerative disorders such as ischemia/anoxia, epilepsy, stroke, trauma and Alzheimer’s
disease. This review describes current knowledge regarding the general properties and functions
of amphiphysin I as well as the functional regulations such as phosphorylation and proteolysis in
nerve terminals.
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Amphiphysin I,  known as a major dynamin-binding partner localized on the collars of nascent vesi-
cles,  plays a key role in clathrin-mediated endocytosis (CME) of synaptic vesicles.  Amphiphysin I 
mediates the invagination and ﬁssion steps of synaptic vesicles by sensing or facilitating membrane 
curvature and stimulating the GTPase activity of dynamin.  Amphiphysin I may form a homodimer by 
itself or a heterodimer with amphiphysin II in vivo.  Both amphiphysin I and II function as multilinker 
proteins in the clathrin-coated complex.  Under normal physiological conditions,  the functions of 
amphiphysin I and some other endocytic proteins are known to be regulated by phosphorylation and 
dephosphorylation.  During hyperexcited conditions,  the most recent data showed that amphiphysin I 
is truncated by the ca2＋-dependent protease calpain.  Overexpression of the truncated form of amphi-
physin I inhibited transferrin uptake and synaptic vesicle endocytosis (SVE).  This suggests that amphi-
physin I may be an important regulator for SVE when massive amounts of Ca2＋ ﬂow into presynaptic 
terminals,  a phenomenon observed in neurodegenerative disorders such as ischemia/anoxia,  epilepsy,  
stroke,  trauma and Alzheimerʼs disease.  This review describes current knowledge regarding the gen-
eral properties and functions of amphiphysin I as well as the functional regulations such as phospho-
rylation and proteolysis in nerve terminals.
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he synaptic vesicle membrane is recovered by 
synaptic vesicle endocytosis (SVE) after synap-
tic vesicles are released to the synaptic plasma mem-
brane during synaptic transmission.  Several modes of 
retrieval have been proposed to operate at small syn-
aptic terminals of central neurons.  They are classical 
clathrin-mediated endocytosis (CME),  nonclassical 
“kiss and run”,  and bulk endocytosis.  The classical 
CME is a slow track in which vesicles fuse completely 
with the presynaptic plasma membrane,  followed by 
clathrin-mediated recycling of the vesicular compo-
nents [1].  Nonclassical “kiss and run” is a fast track 
that may correspond to the transient opening and clos-
ing of a fusion pore [2].  Though the relative impor-
tance of both has been controversial,  recent studies 
have shown that CME is the major mechanism for 
maintaining the synaptic vesicle recycling pool for 
synaptic transmission during repetitive high-frequency 
electrical stimulation (HFS) and physiological stimula-
tion [3-5].  Bulk endocytosis was induced during 
continuous and strong stimulations such as those that 
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occur with high potassium treatment in central syn-
apses [6,  7].  Ca2＋-dependent phosphatase 2B cal-
cineurin activity [8],  actin polymerization [9],  and 
F-BAR-containing endocytic protein syndapin [10],  
but not dynamin I (the major pinchase in synapses) 
[11],  have been reported to be involved in this pro-
cess.  But the detailed molecular mechanism about bulk 
SVE remains to be deﬁned.
　 CME has been divided into 4 steps: nucleation,  
invagination and contraction,  ﬁssion,  and uncoating 
[12].  Many endocytosis-related proteins are recruited 
to form complexes on the retrieved pits at each step 
after neural excitation activates calcium/calmodulin-
dependent calcineurin activity.  These proteins include 
clathrin,  AP2,  AP180,  dynamin,  amphiphysin,  endo-
phillin,  synaptojanin,  intersectin,  syndapin,  auxillin,  
HSC70 ATPase and so on [13].  Amphiphysin I is 
suggested to be colocalized with dynamin 1 on the 
collar of the retrieved pits [14].  It senses and facili-
tates membrane curvature [15] and stimulates the 
GTPase activity of dynamin in the presence of lipid 
membrane [16],  and thus is involved in the invagina-
tion and ﬁssion steps of clathrin-mediated SVE.  
Besides its interaction with dynamin 1,  amphiphysin I 
also interacts with clathrin heavy chain [17],  α
-appendage of AP2 [18],  endophilin [19],  synaptoja-
nin [20],  Cdk5 activator p35 [21],  PLD (phospho-
lipase D) [22] and cain [23].
　 CME is regulated by the phosphorylation and 
dephosphorylation of endocytic proteins.  When nerve 
terminals in the brain are stimulated,  a group of 
phosphoproteins (called dephosphins,  including 
dynamin 1,  amphiphysins I and II,  synaptojanin,  
epsin,  eps15,  and AP180) are coordinately dephos-
phorylated by calcineurin [13].  The switching from 
the phosphorylated state of the endocytic proteins to 
the dephosphorylated state after nerve terminal depo-
larization is essential for triggering the CME.  After 
one round of stimulation,  following the synaptic mem-
brane repolarization,  all the phosphoproteins will be 
rephosphorylated before the next round of stimulation.  
Endocytic protein phosphorylation can regulate a 
variety of protein-protein and protein-lipid interac-
tions [24-29].  In vitro experiments showed that a lot 
of kinases are involved in the phosphorylation of 
endocytic proteins in the resting conditions.  They 
include cdk5,  cdc2,  PKC,  CK2,  PKA,  MAPK,  
AAK1,  GAK,  and Src-family kinases [30].
　 CME may also be regulated by the proteolysis of 
endocytic protein during hyperexcitation,  such as 
repetitive HFS or high potassium stimulation.  It has 
been found that amphiphysin I is truncated to 
N-terminal fragments by the Ca2＋-dependent protease 
calpain under high potassium stimulation in mice hip-
pocampal slices.  Overexpression of the amphiphysin I 
truncation inhibited clathrin-mediated transferrin 
uptake in Cos-7 cells and synaptic vesicle endocytosis 
in neurons.  Calpain-dependent amphiphysin I trunca-
tion is involved in HFS-induced postsynaptic short-
term depression,  which is thought to be an auto- 
protective mechanism for neurons against 
neuroexcitotoxicity.  Further,  calpain-dependent 
amphiphysin I truncation is also observed in kainate 
(KA)-induced seizures in FVB/NJ mice.  Amphiphysin 
I cleavage by calpain may play a part in reducing the 
development of seizures in vivo [31].
General Properties of Amphiphysin I and  
Its Function in SVE
　 Amphiphysin I is an acidic,  hydrophilic protein 
that is abundant in the nervous system and concen-
trated in presynaptic terminals; this was originally 
identiﬁed in chicken synaptic vesicle-associated protein 
in 1992.  Chicken amphiphysin I is highly expressed in 
the chicken central nervous system (including fore-
brain,  cerebellum,  hippocampus,  olfactory bulb,  and 
spinal cord) and also in the testis [32].  Similarly,  
human amphiphysin I was later found to be expressed 
highly in the brain and testis.  Its transcripts and 
antigens can also be found at low levels in the ovary,  
pituitary,  pancreas,  and adrenal gland [33-36].  A 
fraction of brain amphiphysin is found to be ﬁrmly 
associated with synaptic vesicles,  but there also 
appears to be a cytosolic pool.  Its cell-type distribu-
tion and its subcellular localization suggest that it may 
participate in mechanisms of regulated exocytosis in 
synapses and certain endocrine cell types.  Human 
amphiphysin I is also highly overexpressed in some 
breast tumors and breast cancer cell lines [37].  It 
was ﬁrst found as an autoantigen in stiﬀ-man syndrome 
associated with breast cancer [33].  But the molecu-
lar mechanism underlying amphiphysin Iʼs role in these 
diseases is not yet clear.
　 Human amphiphysin I is a transcript from chromo-
some 7p13-p14 [38].  So far,  amphiphysin I is known 
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to have 6 splice variants,  one brain amphiphysin I 
(695aa),  one non-neuronal amphiphysin I (653aa,  with 
a deletion of amino acids 425-466) [39],  and 4 retina-
speciﬁc amphiphysin Irs [40].  The brain form 
(695aa) of amphiphysin I is mainly expressed in the 
brain,  whereas the non-neuronal form (653aa) of 
amphiphysin I is predominantly expressed in tissues 
other than brain.  Amphiphysin Ir is speciﬁcally 
expressed in the retina,  and it has been shown to be 
speciﬁcally expressed in rat ribbon synapses [41].  
The diﬀerences among the amino acids sequences of 
the 6 amphiphysin I splice variants are compared in 
Fig.  1.  An isoform of Amphiphysin I,  called amphi-
physin II or Bin 1,  showed similar structure,  func-
tion,  and subcellular localization with amphiphysin I 
in the brain.  Amphiphysin II has 13 splice variants.  
Some are expressed in speciﬁc tissues,  while others 
are ubiquitously expressed [42].  Some studies have 
suggested that amphiphysin I may function in SVE by 
forming a heterodimer with amphiphysin II by their 
N-terminal coiled-coil domains [36,  43].  It appears 
that the relationship with amphiphysin I is important 
for the stability of the brain form of amphiphysin II,  
because amphiphysin II is nearly absent from amphi-
physin I knockout mouse brain even though amphi-
physin II mRNA is unchanged [44].
　 Amphiphsyin I or II is a modular protein from N 
the terminal,  and has an α-helix,  a BAR domain,  a 
proline-rich domain (PRD),  a CLAP domain (clathrin,  
AP2-binding domain),  and a C-terminal SH3 domain 
(Fig.  2).  Each domain plays an important role in 
amphiphysin Iʼs functions.  Amphiphysin I is involved 
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Fig. 1　 Amphiphysin I splice variants expressed in human.  Amphi.  (amphiphysin) I is the canonical human amphiphysin I,  which is 
speciﬁcally expressed in brain.  It contains 695aa and comprises α-helix (33aa in amphi.  II),  BAR,  PRD,  CLAP,  and SH3 domains from 
the N- to C-termini.  The AS (alternative splicing) region (425-466,  42aa) is deleted in other variants.  Amphiphysin I (nonneuronal) is a 
nonneuronal variant of amphiphysin I and has the same amino acid sequence as canonical amphiphysin I except for a deletion at the AS 
region.  Amphiphysin Irs are speciﬁcally expressed in brain retina.  Each of them has 2 insert sequences and one AS deletion.  The ﬁrst 
insert sequence is 3aa at 249.  The second insert sequence occurs at 394,  but the number of inserted aa diﬀers among these 
variants: amphiphysin Irs-1 is 174aa,  amphiphysin Irs-2 is 276aa,  amphiphysin Irs-3 is 580aa,  and amphiphysin Irs-4 is 174aa.  
Amphiphysin Irs-4 has the third insert DNA sequence at 424; it contains 35aa,  but the ﬁfth aa is the stop code TGA,  so Amphiphysin Irs-4 
protein translation is ended at the stop code and the C-terminal region of the canonical amphiphysin I is not contained in amphiphysin Irs-
4.
3
Wu et al.: Amphiphysin I and regulation of synaptic vesicle endocytosis
Produced by The Berkeley Electronic Press, 2009
in the SVE by its interactions with a lot of other 
endocytic components,  including interactions with 
PIP2 of the plasma membrane,  the cdk5/p35 com-
plex,  PLD and amphiphysin II at its N-terminal 
region; interactions with endophilin by the PRD 
domain; interactions with AP2 and clathrin by the 
CLAP domain; and interactions with dynamin I,  syn-
aptojanin and cain by the C-terminal SH3 domain 
(Fig.  2).  Thus,  amphiphysin I not only directly par-
ticipates in the membrane curvature sensing and bend-
ing at the invagination step but also acts as an impor-
tant multilinker protein that recruits various endocytic 
proteins and regulators to the clathrin complex.  CME 
is ﬁnished by the coordinated work of all these endo-
cytic proteins and regulators.  Below we describe the 
interactions of amphiphysin I (domains from the N 
terminus to C terminus) with its partners and how 
these interactions function or regulate SVE.
Interaction with Membrane, p35 and  
PLD at N-terminal Region
　 The N-terminal BAR domain of amphiphysin senses 
and drives plasma membrane curvature,  which is 
important for the invagination step of clathrin-medi-
ated SVE.  The crystal structures of the human and 
Drosophila amphiphysin II BAR domain reveal a 
crescent-shaped homodimer with a positively charged 
concave surface,  suggesting that driving and/or sens-
ing curvatures of membranes by BAR domains occurs 
by the binding of negatively charged membranes to this 
positively charged surface.  The α-helix (1-24) is an 
N-terminal extension with an amphipathic character 
that is predicted to undergo a random coil-to-helix 
transition by binding to the membrane.  The α-helix 
and BAR domain together has been called the N-BAR 
domain.  A crystal structural analysis and molecular 
dynamic simulations suggest that the membrane curva-
ture is generated by the synergistic action of the 
N-terminal helices embedded in the lipid bilayer and 
the charged crescent-shaped dimer acting to remold 
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Fig. 2　 Interactions between amphiphysin I and other endocytic components during clathrin-mediated SVE.  Amphiphysin I is a mul-
tilinker protein.  It interacts with amphiphysin II (amphi.  II),  lipid membrane (PI(4,  5)P2),  cdk5/p35 complex,  and PLD (phospholipase D) at 
the N-terminus concluding BAR domain,  with endophilin (endophi. ) at the PRD domain,  with clathrin (clath. ) and AP2 at the CLAP 
domain,  and with dynamin 1 (dyn.  I),  synaptojanin 1 (synj.  I),  and cain at the C-terminal SH3 domain.  There is a positive feedback 
between PLD and PIP2: PLD will increase PIP2 production by hydrolyzing PC to PA.  PA activates PI(4)P5K activity,  then PIP2 will be 
produced from PI(4)P by PI(4)P5K activity,  while at the same time PIP2 activates PLD.  Amphiphysin I (1-373aa) has been reported to bind 
PLD and to inhibit PLD activity.  The interaction between amphiphysin I and PLD will regulate PIP2 production,  at the same time AP180 
and synj.  I also have an inhibiting eﬀect at PLD activity and thus regulate PIP2-dependent clathrin complex formation.  On the other hand,  
amphiphysin I can regulate CME by recruiting cain (calcineurin inhibitor).  Calcineurin binds dynamin and is recruited to the endocytic zone 
by amphiphysin I to execute its dephosphorylation eﬀect on endocytic proteins,  which is essential for CME induction.  But its activity will 
be downregulated by its inhibitor,  cain.  This may promote cdk5-dependent rephosphorylation and dissociation of endocytic protein.  
Besides the association with amphiphysin I,  the schematic ﬁgure also shows the interactions among other endocytic proteins (thin line).
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membrane curvature [15,  45-49].
　 There are 2 conserved regions in human Bin 1 
BAR and drosophila amphiphysin BAR domains with 
weak potential (compared with those of arfaptin and 
endophilin or that of the IMD domain of IRSp53) for 
protein-protein interaction,  as detected by a computa-
tional approach.  Since these sites are in the convex 
face of the BAR domain,  would not interrupt the 
binding properties of the concave face directly.  The 
protein-protein interaction sites is expected to be 
important for modulating the membrane-binding activ-
ity of the BAR domain by interacting with some other 
partner proteins [46].
　 So far,  2 proteins have been reported to interact 
with the amphiphysin I N-terminal.  But they are not 
likely to be involved in the regulation of BAR domain 
binding activity. One is p35,  an activator of cyclin-
dependent kinase (Cdk5).  Amphiphysin I is a substrate 
for Cdk5 [50],  a member of the cyclin-dependent 
protein kinase family,  which has been functionally 
linked to neuronal migration and neurite outgrowth via 
its action on the actin cytoskeleton.  p35,  the activat-
ing subunit of the Cdk5 kinase complex,  has been 
found to interact with the amphiphysin I N-terminal 
region (1-306aa) in rat brain and in vitro [21].  This 
interaction is analogous to the Pcl2-Rvs167 interaction 
in yeast [51].  The yeast homologue of amphiphysin I,  
Rvs167,  functions in endocytosis and actin dynamics,  
is phosphorylated by the Cdk5 homologue Pho85,  and 
binds the Pho85 regulatory subunit Pcl2.  The inter-
action between p35 and the amphiphysin I N-terminal 
region may be important for amphiphysin I or other 
endocytic protein phosphorylation by Cdk5 in resting 
conditions,  and thus may be an important SVE-
regulating pathway.
　 The other protein that is known to interact with the 
amphiphysin I N-terminal is phospholipase D (PLD).  
PLD hydrolyzes the phosphodiester bond of the glyc-
erolipid phosphatidylcholine,  resulting in the produc-
tion of phosphatidic acid (PA) and free choline.  PA is 
widely considered to be the intracellular lipid media-
tor of many of the biological functions attributed to 
PLD.  In mammalian systems,  PLD activity regulates 
the actin cytoskeleton,  vesicle traﬃcking for secretion 
and endocytosis,  and receptor signaling.  PLD is 
activated by phosphatidylinositol-4,  5-bisphosphate 
(PI(4,  5)P2),  protein kinase C (PKC),  ADP ribosyla-
tion ractor (ARF1) and Rho family GTPases.  PLD 
has 2 isoforms,  PLD1 and PLD2.  PLD1 has been 
reported to be localized to membranous structures:  
Golgi,  endoplasmic reticulum,  endosome,  lysosome,  
and plasma membrane.  PLD2 is most often reported 
to localize to the plasma membrane,  but also localizes 
to the cytosol and submembranous vesicular compart-
ments as well as co-localizing with β-actin [see 
review 52].  Four nerve-terminal concentrated and 
clathrin-coat-associated proteins have been related to 
PLD activity inhibition: synaptojanin [53],  AP180 
[54],  amphiphysin I and amphiphysin II [22].  The 
inhibition of PLD by synaptojanin was attributed to its 
ability to dephosphorylate PI(4,  5)P2,  whereas the 
inhibitory eﬀects of AP180,  amphiphysins I and II are 
the result of direct interaction with PLD.  Amphi-
physin I and II N-terminal (1-373aa) is critical for 
PLD binding and inhibition activity.  The inhibition of 
PLD activity by synaptojanin,  AP180 and amphi-
physins I and II is thought of as a negative regulation 
for clathrin coat assembly.  Because the PI(4,  5)P2 
component in the plasma membrane is important for 
clathrin coat assembly [55-60],  at the same time it is 
an activator for PLD activity.  PA,  produced by the 
action of PLD,  is a potent activator of PI(4)P 
5-kinase [61-64] and thereby increases the synthesis 
of PI(4,  5)P2,  which,  in turn,  leads to further stimu-
lation of PLD activity.  A rapid increase in the con-
centration of PI(4,  5)P2 induced by this positive 
feedback loop would be expected to facilitate clathrin 
coat assembly.  Inhibition of PLD by amphiphysins and 
AP180,  together with the hydrolysis of PI(4,  5)P2 by 
synaptojanin,  provides a mechanism to break the 
feedback loop (Fig.  2),  which is important for coated 
vesicle disassembly and its subsequent fusion with 
plasma membrane.
　 These observations suggest that,  aside from the 
sensing and/or driving membrane curvature in the 
invagination step,  the conserved N-terminal region/
BAR domain of amphiphysin I may also be involved in 
the phosphorylation of amphiphysin I and other endo-
cytic proteins by cdk5 under resting conditions,  as 
well as in regulating membrane PI(4,  5)P2 levels and 
thus coated vesicle disassembly during synaptic activ-
ity.
Interaction with Endophilin at PRD Domain
　 The N-BAR domain is followed by a positively 
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charged stretch (248-315) that is very rich in proline 
(32ｵ) and other small amino acids.  Because of its 
high proline content,  the proline-rich domain (PRD) 
harbors potential SH3-binding and proline-directed 
kinase phosphorylation sites.  The sequences of both 
the N-BAR domain and the PRD domain are highly 
conserved among diﬀerent species (for example,  94ｵ 
of identity between chicken and human).  Endophilin 1 
has been reported to interact with the amphiphysin I 
and II PRD domains by its SH3 domain speciﬁcally 
[19].  Endophilin 1,  a cytoplasmic Src homology 3 
(SH3) domain-containing protein,  localizes in brain 
presynaptic nerve terminals.  Endophilin dimerizes 
through its N-terminus [65] and participates at mul-
tiple stages in CME,  such as inducing CME initiation 
as a Ca2＋ sensor,  driving early membrane invagination 
by its BAR domain and uncoating synaptic vesicles by 
recruiting synaptojanin in synapses [66-75].  Both its 
C-terminal SH3 domain and the N-terminus are 
required for endocytosis.  Through its SH3 domain,  
endophilin binds to PRDs in other endocytic proteins,  
including synaptojanin and dynamin [72,  73,  76] 
except amphiphysins.  The N-terminal region possesses 
unique functions aﬀecting lipid membrane curvature 
[77].  Endophilin is another important N-BAR 
domain-containing endocytic protein.  Previous studies 
proposed that endophilin binds to tubulate membrane 
through its BAR domain and its lysophosphatidic acid 
acyl transferase (LPAAT) activity.  By the LPAAT 
activity,  arachidonate transfer to lysophosphatidic 
acid generated phosphatidic acid in the membranes.  
This activity is thought to change the bilayer asym-
metry in such a way that negative membrane curvature 
at the neck of a budding vesicle will be stabilized 
[78].  But recently,  the LPAAT activity associated 
with endophilin proved to be a contaminant of the 
puriﬁcation procedure [79].  The proposed locus of 
activity in endophilin includes the BAR domain,  which 
has no catalytic site but instead senses positive mem-
brane curvature.  Amphiphysin and endophilin BAR 
domains have similar tertiary and quaternary struc-
turesas well as amphipathic properties in N-terminal 
α-helices,  except for the signiﬁcant diﬀerence that 
endophilin has a short loop,  disordered in the middle 
of a crescent-like crystal,  on the concave surface of 
helix 1.  The protrusion coming from the middle of the 
endophilin BAR domain crystal has been suggested to 
be another structure-based mechanism that helps to 
drive membrane curvature by its insertion into the 
membrane bilayers [80].  Amphiphysin I and endophi-
lin1 have similar properties in binding with lipid 
membrane in vitro,  including the diameters of the lipid 
tubules and the recruitment of dynamin and clathrin 
coat protein to lipid tubules.  But they showed diﬀer-
ent eﬀects on dynamin 1 GTPase activity in vitro;  
whereas amphiphysin I has a stimulatory eﬀect,  endo-
philin has an inhibitory eﬀect on vesicle formation 
when added with dynamin and GTP to liposomes [77].  
The study using anti-endophilin antibody microinjec-
tion into lamprey giant reticulospinal pre-synapse 
showed that SVE was inhibited at an earlier invagina-
tion stage and that synaptic vesicles were trapped by 
shallow clathrin-coated pits (CCPs) [66].  In contrast,  
interruption of amphiphysin I by the amphi-SH3 
domain showed the inhibition of SVE at a very late 
invagination stage or ﬁssion step,  where SVs were 
trapped by constricted CCPs [81].  Together,  these 
ﬁndings suggest that the membrane-binding property 
of endophilin may be more necessary at an earlier 
stage of the invagination step of clathrin-mediated 
SVE compared with amphiphysin I,  in which GTPase 
activity increases during the ﬁsson step.  But how 
these two N-BAR proteins coordinately work and the 
importance of the interaction between them needs to 
be explored further.
Interaction between Clathrin and AP2 at the 
CLAP Domain
　 Clathrin triskelia and adaptor protein complexes 
(APs) are the major coat proteins involved in CME.  
The formation of a cage structure from clathrin helps 
to invaginate the membrane and shape vesicles.  AP2 
was shown to bind and cluster transmembrane proteins 
destined for internalization and to promote clathrin 
polymerization on the plasma membrane.  The CLAP 
domain (322-386) in the middle of amphiphysin I is 
shown to interact with the clathrin heavy chain and the 
α-appendage of AP2 directly.  The interaction 
between clathrin and AP2 has been reported to be 
essential for receptor-mediated transferrin endocyto-
sis by overexpression of amphiphysin I fragments that 
contain both clathrin heavy-chain- and AP2-binding 
domains in CHO cells [82].  Mutation of residues 323 
to 326 (FFED) abolishes α-adaptin binding without 
aﬀecting clathrin heavy-chain binding.  Binding to the 
310 Acta Med.  Okayama　Vol.  63,  No.  6Wu et al.
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clathrin heavy chain is conferred by residues 347 to 
386 [82].  The three-dimensional structure of the 
α-adaptin appendage domain has been determined and 
a model has been proposed to account for its remark-
able ability to mediate binding not only to amphi-
physin 1 but also to Eps15 and epsin in clathrin coats 
via a single interaction interface [83,  84].  Muta-
tional analysis identiﬁed 2 motifs (LLDLD and 
WDLW) in amphiphysin II that are important for 
binding to the clathrin heavy chain.  The aﬃnity of the 
recombinant clathrin-binding domain of amphiphysin II 
for native clathrin triskelia was estimated to be 1nM 
[85].  The mutation of either LLDLD or WDLW 
motifs in amphiphysin I weakens clathrin heavy-chain 
binding,  and the double mutation abolishes clathrin 
heavy-chain binding but has no eﬀect on α-adaptin 
binding.  As expected,  the combination of the muta-
tions in α-adaptin and the clathrin heavy-chain binding 
sites abolished amphiphysin I interaction with both 
α-adaptin and the clathrin heavy chain [82].
Interaction with Dynamin 1
　 Dynamin plays an important function in the ﬁssion 
of endocytic buds from the plasma membrane.  An 
essential role for dynamin in all forms of SVE has 
been strongly suggested by studies with dynasore,  
which rapidly inhibits the GTPase activity of dynamin 
with high speciﬁcity and potently inhibits synaptic 
vesicle recycling in rodent hippocampal neurons [86].  
Mammals express three dynamins with diﬀerent 
expression patterns.  Dynamin 1 is expressed exclu-
sively in the brain,  whereas dynamin 2 is ubiquitously 
expressed and dynamin 3 is expressed selectively in 
brain and testis.  In the neurons,  dynamin 1 is present 
at overwhelmingly high levels compared to dynamin 2 
or 3.  However,  surprisingly,  the nervous-system-
speciﬁc dynamin 1,  and by far the major dynamin in 
neurons,  is largely dispensable for the endocytic 
recycling of SVs in dynamin 1 knockout mice cortical 
neurons [87].  Dynamin 1 becomes essential only 
when an intense stimulus imposes a heavy load on 
endocytosis and only as long as the stimulus persists.  
The defects in SVE could be rescued with WT 
dynamin 1 or dynamin 3 overexpression in dynamin 1 
KO cortical neurons,  which suggests that dynamin 3 
may compensate for dynamin 1ʼs function in the 
absence of dynamin 1.  Nevertheless,  lines of proof 
showed that dynamin 1 play a key role in clathrin-
mediated SVE.  The role of dynamin in endocytosis 
was established when the Drosophila gene shibire was 
cloned in 1991 and was found to be homologous to 
dynamin [88,  89].  Drosophila expressing the temper-
ature-sensitive shibire gene product exhibit rapid and 
reversible paralysis at a nonpermissive temperature.  
Examination of the nerve terminals of the shibire ﬂies 
at the nonpermissive temperature revealed an absence 
of synaptic vesicles and the accumulation of clathrin-
coated pits at the plasma membrane.  This led to 
speculation that dynamin plays a role in CME [90].  In 
vitro,  dynamin spontaneously self-assembled into rings 
and stacks of interconnected rings,  comparable in 
dimension to the ʻcollarsʼ observed at the necks of 
invaginated coated pits that accumulate at synaptic 
terminals in shibire ﬂies [91].  In GTPγS (a nonhy-
drolized form of GTP)-treated nerve terminals,  elon-
gated tubular invaginations of plasmalemma were 
found to be decorated by dynamin-formed transverse 
electron-dense rings [92].  Ultrastructural analysis of 
GTPγS-injected nerve terminals also showed dynamin 
is localized on invaginated clathrin-coated pits and 
forms a ring structure on the neck [93].  All these in 
vitro and in vivo studies indicate an important role for 
dynamin at the ﬁssion step by the assembly of dynamin 
into rings around the neck of clathrin-coated pits,  and 
a concerted conformational change is expected to pinch 
oﬀ the coated vesicles.  Further,  ﬂuorescence micro-
scopic and electron microscopic analyses of dynamin 1 
KO neurons revealed a dramatic accumulation of 
clathrin-coated pits in inhibitory synapses,  suggesting 
that clathrin-mediated SVE is seriously inhibited at 
the ﬁssion step in dynamin 1 KO synapses [11].
　 Both amphiphysin I and II have SH3 domains at the 
C-terminal that recognize the PSRPNR sequence 
within dynaminʼs PRD domain [94].  In vitro,  the 
amphiphysin I-SH3 domain bound the dynamin I-PRD 
domain with high aﬃnity (KD～10nM) [95].  Confocal 
immunoﬂuorescence revealed that COS-7 cells trans-
fected with the amphiphysin SH3 domain showed a 
potent blockade in receptor-mediated endocytosis.  
When COS-7 cells were cotransfected with both 
dynamin and the amphiphysin I SH3 domain,  transfer-
rin uptake was eﬃciently rescued.  Importantly,  the 
SH3 domains of Grb2,  phospholipase Cγ and spectrin 
all failed to exert any eﬀect on endocytosis [96].  
Microinjection of amphiphysinʼs SH3 domain or of a 
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dynamin peptide containing the SH3 binding site inhib-
ited synaptic vesicle endocytosis at the stage of 
invaginated clathrin-coated pits,  which resulted in an 
activity-dependent distortion of the synaptic architec-
ture and a depression of transmitter release [81].  
These ﬁndings demonstrate that SH3-mediated inter-
actions are required for dynamin function and support 
an essential role of CME in synaptic vesicle recycling.
　 Amphiphysin I plays a critical role in CME by 
recruiting dynamin to the nascent vesicle neck and 
stimulating dynaminʼs GTPase activity.  Microinjection 
of the amphiphysin SH3 domain induced trapped 
CCPs,  and no dynamin ring structure could be found 
on the vesicle neck [81],  suggesting that dynamin 
recruitment to the neck is inhibited by the interrup-
tion of interaction between amphiphysin SH3 and the 
dynamin PRD domain.  Microtubules [97,  98],  
growth factor receptor-bound protein 2 (Grb2) [98] 
and anionic phospholipids (small liposomes) [99] have 
been shown to stimulate the GTPase activity of 
dynamin,  and each of these substrates promotes 
dynamin assembly [100].  Similarly,  amphiphysin I 
could form a ring structure with dynamin under the 
same physiological buﬀer conditions.  In this way,  
dynamin molecules are polymerized in the rings and 
are in close enough proximity for the GED domain of 
one molecule to make contact with the GTPase domain 
of a neighboring molecule,  resulting in the stimulation 
of dynamin GTPase activity [101,  16].  Liposome 
size strongly inﬂuences amphiphysinʼs eﬀect on 
dynamin GTPase activity.  In the presence of large 
liposomes (1779.57± 461.7nm in diameter),  dynamin 
GTPase activity is dramatically enhanced by the addi-
tion of amphiphysin.  On the other hand,  when the 
liposomes are small (80.77± 10.8nm in diameter),  the 
addition of amphiphysin I led to a drastic decrease in 
GTPase activity.  This suggests that amphiphysin I can 
sense plasma membrane curvature and thus can regu-
late dynamin GTPase activity or the assembly/disas-
sembly of amphiphysin complex with dynamin.  At the 
same time,  the lipid component also inﬂuences the 
stimulatory eﬀect of amphiphysin on dynamin GTPase 
activity.  A higher concentration of PI(4,  5)P2 or 
phosphatidylserine (PS) to liposome could increase 
the stimulatory eﬀect more strongly.  In addition,  both 
the BAR and SH3 domains are required for the stimu-
lation of dynamin GTPase activity and ring structure 
formation with dynamin.  The deletion of central 
regions of the amphiphysin molecule Amph Δ248-601,  
containing the BAR and SH3 domains,  strikingly 
enhanced the eﬀect of amphiphysin I on dynamin 
GTPase activity.  This is thought of as intramolecular 
interaction between the PRD domain and SH3 
domain; this interaction blocks the binding of amph-
iphysin with the dynamin PRD domain by the SH3 
domain [101,  102].
Interaction with Synaptojanin 1
　 Synaptojanin 1 is the only other brain protein that 
binds the SH3 domain of amphiphysin with an impor-
tant function in synaptic vesicle endocytosis.  Synap-
tojanin 1 has 2 distinct phosphatase domains: a Sac 
1-like inositol phosphatase domain near the amino 
terminus,  and a central inositol 5-phosphatase domain.  
A third important region is the C-terminal proline-
rich domain (PRD) that interacts with endocytic pro-
teins,  including endophilin and amphiphysin.  The 
amino-terminal Sac 1-like phosphatase hydrolyzes 
PI(3,  5)P2,  PI(4)P,  or PI(3)P to PI [103],  whereas 
the central 5-phosphatase hydrolyzes PI(4,  5)P2 to 
PI(4)P [104].  A recent study revealed that synapto-
janin 1 (145-kDa),  the predominant isoform expressed 
in the brain,  was rapidly recruited as a “burst, ” 
together with endophilin,  at a late stage of CCP for-
mation [105].  In contrast,  the nonneuronal ubiqui-
tously expressed 170-kDa isoform of synaptojanin was 
present at all stages of CCP formation,  which is 
important for clathrin coat maturation in nonneuronal 
cells.  These results raise the possibility that dynamic 
phosphoinositide metabolism may occur throughout the 
lifetime of a CCP.  Genetic ablation of synaptojanin 1 
in mice [106],  worms [107],  and ﬂies [73] causes 
depressed synaptic transmission after prolonged 
stimulation,  decreased synaptic vesicle numbers,  and 
accumulation of clathrin-coated vesicles,  suggesting 
that synaptojanin 1 regulates the uncoating and remo-
bilization of vesicles during CME.  In the nerve termi-
nal,  synaptojanin 1 forms 2 separate complexes by 
distinct sites in its PRD domain at the same time: 1 is 
interaction with endophilin by site PKRPPPPR,  and 
the other is interactions with amphiphysin I,  II by 2 
sites,  PIRPSR and PTIPPR [108,  109].  Though 
amphiphysins I and II have been reported as partners 
of synaptojanin,  no further studies have shown the 
signiﬁcance of the interaction in clathrin-dependent 
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endocytosis.  In contrast,  endophilin as the major 
partner of synaptojanin showed an important role in 
SVE.  Manipulations of endophilinʼs SH3 domain 
caused an accumulation of deeply invaginated pits and 
clathrin-coated vesicles at the lamprey giant synapse 
[66],  suggesting that endophilin plays an important 
role in recruiting synaptojanin and dynamin I to the 
clathrin coat for endophilin during SVE.  
Amphiphysin I is Involved in Regulating 
Calcineurin Activity
　 Following exocytosis,  synaptic vesicle components 
are recovered by endocytosis.  Ca2＋ inﬂux into the 
nerve terminal is not only the trigger for exocytosis 
but is also important for clathrin coat nucleation in 
SVE.  Ca2＋/calmodulin-dependent phosphatase 2B 
calcineurin plays an essential role in endocytosis by 
dephosphorylating the dephosphins: dynamin 1,  syn-
aptojanin,  epsin 1,  eps 15,  and AP180 except amphi-
physins I and II.  The dephosphorylation of all these 
dephosphins is essential for endocytosis [13].  Cal-
cineurin binds dynamin 1 at the dynamin 1 C-terminal 
PRD domain.  The calcineurin-dynamin 1 interaction 
is calcium-dependent,  with an EC50 for calcium in the 
range of 0.1-0.4µM.  Disruption of the calcineurin-
dynamin 1 interaction inhibits CME.  Thus,  the cal-
cium-dependent formation of the calcineurin-dynamin 1 
complex provides a calcium-sensing mechanism that 
facilitates endocytosis.  Amphiphysin I is also com-
bined with this calcium sensor complex,  the addition 
of amphSH3 peptide,  which corresponds to the bind-
ing sites with dynamin PRD domain.  This causes both 
dynamin 1 and calcineurin to dissociate from the 
GST-amphiphysin 1 column,  showing that amphi-
physin I plays an anchoring role for the calcineurin-
dynamin 1 complex to clathrin-coated pits through the 
interaction between amphiphysin I and dynamin 1 
[110].  On the other hand,  amphiphysin I also recruits 
cain (calcineurin inhibitor) by its SH3 domain binding 
to the cain PRD domain.  Cain is a 240-kDa protein 
that binds to calcineurin and inhibits calcineurin activ-
ity.  Cain overexpression in HEK293 cells blocks 
transferrin-induced endocytosis,  suggesting it has a 
regulatory role in CME.  Co-immunoprecipitation 
experiments showed that cain binds to calcineurin and 
amphiphysin I simultaneously.  These data suggest that 
amphiphysin I has a two-sided eﬀect on calcineurinʼs 
dephosphorylation action.  Upon calcium inﬂux into the 
nerve terminal,  amphiphysin I recruits the cal-
cineurin (active)-dynamin 1 complex to the plasma 
membrane or partly formed clathrin coat,  delivering 
calcineurinʼs dephosphorylation eﬀect to the complex 
of endocytic proteins.  Once the endocytic coat com-
plex is fully assembled,  cain,  another partner associ-
ated with amphiphysin 1,  promotes the rephosphory-
lation and dissociation of endocytic proteins by 
inactivating calcineurin [23].
A Potential Role in Actin Function
　 The dynamic polymerization of actin has a central 
role in several processes that reshape the plasma 
membrane.  These processes include the protrusion of 
lamellipodia and ﬁlopodia during cell migration,  and 
diﬀerent forms of endocytic internalization (phagocy-
tosis,  macropinocytosis,  clathrin-mediated endocyto-
sis and caveolae-mediated endocytosis) [111].  
Neurons express only the β and γ isoforms of actin,  
lacking the α isoform popular with skeletal muscle.  
Actin is ubiquitously expressed in neurons.  Inter-
estingly,  it is highly concentrated at synapses.  Both 
light microscopy and ultrastructural studies indicate 
that,  at mammalian CNS synapses,  actin is most 
highly enriched in postsynaptic dendritic spines.  It is 
also indeed enriched in presynaptic nerve terminals 
relative to the adjacent axon segment.  In developing 
synapses,  the rapid turnover of actin facilitates axon 
outgrowth,  de novo synapse formation,  molecular 
scaﬀolding,  and synaptic plasticity.  Actin has many 
potential roles in nerve endings,  and its eﬀects have 
been classiﬁed into 4 broad categories: a barrier 
eﬀect,  in which polymerized actin is distributed under 
plasma membrane and between synaptic vesicles,  
which can impede vesicle fusion; a carrier eﬀect,  in 
which the highest concentration of actin reportedly 
often appeared to surround the core of synaptic vesi-
cle clusters,  forming a corral to restrain vesicles from 
fusion with plasma membrane too; a recycler eﬀect,  in 
which active polymerization of actin could facilitate 
endocytic recycling of fused vesicles by constriction or 
propulsion forces; and a scaﬀold eﬀect,  in which actin 
might act as a scaﬀold to sequester regulatory mole-
cules at or near the vesicle pools [112].  The func-
tional links between actin cytoskeleton and CME have 
been identiﬁed.  Actin polymerization has been 
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involved in earlier and later stages of SVE in lamprey 
reticulospinal synapses.  At stimulated synapses,  
speciﬁc disruption of actin polymerization with latrun-
culin and swinholide (2 actin polymerization inhibitors) 
induced a selective increase in unconstructed clathrin-
coated pits and,  in the case of swinholide,  an addi-
tional increase in the size of plasma membrane evagi-
nations.  These results indicate that actin 
polymerization participates initially in the maturation 
of CCPs during the early stages of synaptic vesicle 
recycling [113].  Ultrastructural observations of 
stimulated lamprey synapses in the presence of 
F-actin-stabilizing reagents,  phalloidin,  and an 
N-ethylmaleimide-inhibited subfragment of myosin I 
(NEM-S1) caused tethered vesicles or accumulated 
aggregates of vesicles,  suggesting that actin disas-
sembly is involved in transporting vesicles back to the 
synaptic vesicle pool [114].
　 Amphiphysin I and dynamin I are colocalized on the 
nascent vesicle neck.  The interaction is essential for 
the clathrin-mediated SVE.  So far,  though,  there is 
no direct proof showing amphiphysin is involved in 
actin function in synaptic vesicle endocytosis.  Several 
studies have suggested that amphiphysin has a poten-
tial role in actin polymerization.  First,  amphiphysin 
homologs in yeast Rvs 167p and Rvs 161p are known 
to be physically linked to actin cytoskeleton,  or actin-
binding protein Abp1p,  positioning the Rvs 167p in 
the heart of the actin cytoskeleton.  Genetic and func-
tional analyses of rvs mutant showed a loss of actin 
cables and the de-localization of actin spots under 
adverse conditions,  defects concerns disorders in 
endocytosis,  bud-site selection and mating.  These 
phenotypes are close to those described for the actin 
mutants [115].  Second,  amphiphysin I colocalizes 
with dynamin I in developing neurons at all develop-
mental stages and that a pool of both proteins is 
colocalized with actin patches at the leading edges of 
growth cones.  When amphiphysin I was knocked out 
with amphiphysin I antisense oligonucleotides,  growth 
cones collapsed and both neurite outgrowth and axon 
formation were severely inhibited.  These data suggest 
a conserved role of the amphiphysin protein family in 
the dynamics of the cortical cell cytoskeleton [116].  
Third,  in Sertoli cells,  amphiphysin I is enriched in 
actin-rich structures,  including ruﬄes,  phagocytic 
cups,  and phagosomes after PS-liposome or PS-coated 
bead stimulation.  Knocking out amphiphysin 1 by RNA 
interference in the cells resulted in reductions in ruﬄe 
formation,  actin polymerization,  and phagocytosis.  
Phagocytosis was also drastically decreased in amph 1 
(－/－) Sertoli cells.  In addition,  PI(4,  5)P2-induced 
actin polymerization was decreased in the knockout 
testis cytosol.  The addition of recombinant amphi-
physin 1 to the cytosol restored the polymerization 
process.  Ruﬄe formation in small interfering RNA-
treated cells was recovered by the expression of con-
stitutively active Rac 1,  suggesting that amphiphysin 
1 functions upstream of the Rac 1 signal pathway 
[117].  These ﬁndings support that amphiphysin 1 is 
important in the regulation of actin dynamics and that 
it is required for phagocytosis.  The molecular mecha-
nism underlying amphiphysinʼs role in actin polymer-
ization and its ability to further amphiphysinʼs eﬀect 
on SVE remains unclear.
Regulation of the Functions of Amphiphysin I 
by Phosphorylation
　 Amphiphysin I also undergoes constitutive phos-
phorylation and stimulation-dependent dephosphoryla-
tion.  Dephosphorylation of amphiphysin I requires 
extracellular Ca2＋ and is unaﬀected by pretreatment 
of synaptosomes with tetanus toxin.  Thus,  Ca2＋ 
inﬂux,  but not synaptic vesicle exocytosis,  is required 
for dephosphorylation.  Dephosphorylation of amphi-
physin I is inhibited by cyclosporine A and FK-506,  2 
drugs that speciﬁcally block calcineurin activity,  but 
not by okadaic acid,  which blocks protein phos-
phatases 1 and 2B.  This suggests that calcineurin is 
amphiphysin I in vivo phosphatase [118].  All the 
dephosphins have been reported to share the same 
dephosphatase calcineurin,  but each of them may have 
more than one kinase to keep itself in phosphorylated 
form during resting conditions.  All in vivo amphI 
phosphosites have been identiﬁed by 32P tracking in 
synaptosomes [119].  There are 13 of these sites:  
serines 250,  252,  262,  268,  272,  276,  285,  293,  
496,  514,  539,  and 626 and Thr-310 (Fig.  3).  
These were distributed into two clusters,  one around 
the PRD domain and the other around the C-terminal 
SH3 domain.  Hierarchical phosphorylation of Ser-262 
preceded phosphorylation of Ser-268,  -272,  -276,  
and -285.  Oﬄine HPLC separation and two-dimen-
sional tryptic mapping of 32P-labeled amphiphysin I 
revealed that Thr-310,  Ser-293,  Ser-285,  Ser-272,  
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Ser-276,  and Ser-268 contained the highest 32P incor-
poration and were the most stimulus-sensitive.  
Individually,  Thr-310 and Ser-293 were the most 
abundant phosphosites.  Amphiphysin Iʼs in vivo phos-
phorylase activity is not known.  But it is suggested 
that at least one proline-directed protein kinase and 
one nonproline-directed kinase are involved in amphi-
physin I phosphorylation in vivo.  Four phosphosites 
predicted for nonproline-directed kinases,  Ser-626,  
-250,  -252,  and -539,  contained low amounts of 32P 
and were not depolarization-responsive.  The results 
reveal 2 sets of amphiphysin I phosphosites that 
either dynamically turn over or are constitutively 
phosphorylated in nerve terminals.  Two other amphi-
physin I splicing variants were also found to be phos-
phorylated under the same conditions,  but none of the 
phosphosites in amphiphysin I isoform were dynami-
cally labeled with 32P,  and all of the sites are consti-
tutively phosphorylated.  Therefore,  all 3 isoforms of 
amphiphysin I are phosphorylated in nerve terminals,  
but only amphiphysin I dynamically incorporates 32P 
radiation or exhibits depolarization-induced dephos-
phorylation.  This indicates that among the 3 isoforms 
it is the major variant most likely to be involved in 
SVE [119].  In addition to the 13 in vivo phospho-
sites in amphiphysin I induced under physiological 
conditions,  another in vivo phosphosite (T260) was 
found during seizures triggered by the GABA antago-
nist pentylenetetrazole (PTZ) [120].  Under such 
conditions,  activation of the c-jun N-terminal kinase 
(JNK) pathway was detected in hippocampal extracts.  
Phosphorylated amphiphysin I was identiﬁed with the 
cross-activity of speciﬁc phospho-MKK4 antibody,  
which was raised against the phosphorylation peptide 
of the upstream JNK kinase MKK4.  The protein 
kinases for amphiphysin I phosphosite T260 remain to 
be identiﬁed.  The phosphorylation found speciﬁcally 
during PTZ-induced synaptic hyperexcitation suggests 
a potential role for amphiphysin I in synaptic function 
under neuronal hyperexcitation.
　 The protein kinase or kinases that phosphorylate 
amphiphysin I in nerve terminals in vivo are not known,  
but amphiphysin I is a substrate for at least 4 protein 
kinases in vitro.  Three proline-directed protein kinases 
phosphorylate amphiphysin I: Cdk5/p35 (Ser-262,  
Ser-272,  Ser-276,  Ser-285,  and Thr-310) [50],  
mitogen-activated protein kinase (MAPK) (Ser-285 
and Ser-293) [121],  and Mnb/Dyrk1A (Minibrain 
kinase/dual-speciﬁcity tyrosine phosphorylation-regu-
lated kinase) (Ser-293 with minor sites including Thr-
310,  and Ser-295) [122].  CK2 phosphorylates amphI 
in vitro on Thr-350 and Thr-387 [123].  The phospho-
rylation at these sites is important for regulating the 
interactions of amphiphysin I with its endocytic part-
ners,  clathrin,  AP2,  endophilin and lipid membrane,  
but its interaction with dynamin is not.  Compared 
with the other 3 potential amphiphysin I kinases 
(MAPK,  Dyrk1A/minibrain kinase,  and CK2),  Cdk5 
is more likely important amphiphysin I in vivo kinase,  
because the 5 Cdk5-dependent phosphosites in amph-
iphysin I identiﬁed in vitro are all consistent with those 
identiﬁed in vivo.  Four of these phosphosites (except 
S262) could highly incorporate 32P and are the most 
stimulus-sensitive in the nerve terminal.  In addition,  
amphiphysin I has been detected in the Cdk5/p25 
complex in bovine brain [124],  and the Cdk5-
activating subunit p35 has been reported to bind the N 
terminus of amphiphysin I in rat brain [21].  In some 
experiments,  2 Cdk5 inhibitors,  roscovitine and 
Ro31-8220,  could not inhibit amphiphysin I rephos-
phorylation completely upon recovery from a depolar-
ization stimulus [125,  126],  and the phosphorylated 
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Fig. 3　 In vivo phosphosites of amphiphysin I.  There are 13 phosphosites (S250,  252,  262,  268,  272,  276,  285,  293,  496,  514,  539,  
626,  and T310) found in rat brain.  T260 (red) was found in GABA antagonist PTZ-induced seizure.  The phosphosites of S268,  272,  276,  
285,  293,  T310 (black bold) are most dynamically turning over,  and the phosphosites of S250,  252,  539,  626 (blue bold) are most con-
stitutively phosphorylated during the synaptic activity.  Cdk5,  MAPK,  and Mnb/Dyrk1A are potential in vivo kinases; they phosphorylated 
amphiphysin I at the sites shown in the ﬁgure in vitro.
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form of amphihysin I still exists in synaptosomes from 
p35-deﬁcient mice [50].  These data indicate that 
Cdk5 is not only a kinase for amphiphysin I in vivo,  but 
that some other kinases could compensate for Cdk5ʼs 
role in the phosphorylation of amphiphysin I when cdk5 
activity is blocked.
　 Cdk5 co-phosphorylates amphiphysin I and dynamin 
I in vitro [50].  Amphiphysin I can copolymerize with 
dynamin I into ring structures and has a stimulatory 
eﬀect on dynamin Iʼs GTPase activity in vitro; this 
eﬀect is highly dependent on liposome size [16].  
Cdk5-dependent phosphorylation regulates the interac-
tion between amphiphysin I and dynamin I.  The phos-
phorylation of each protein reduces the copolymeriza-
tion into a ring formation.  Moreover,  the 
phosphorylation of both proteins completely disrupts 
the copolymerization into a ring formation.  Further,  
the dynamin I GTPase activity-dependent vesicle for-
mation from liposome is also inhibited by the phospho-
rylation of both proteins [50].  On the other hand,  
cdk5-dependent phosphorylation also regulates the 
interaction of amphiphysin I with the lipid membrane 
[28].  It is interesting that cdk5-dependent phospho-
rylation of amphiphysin I was enhanced in the presence 
of liposome in vitro,  and that the phosphorylation was 
markedly decreased by mutation of either Ser276 or 
Ser285 of amphiphysin I to alanine (S276A and 
S285A).  Furthermore,  mutation of both sites (S276 
and 285A) completely eliminated the enhanced phos-
phorylation.  Functional studies indicated that binding 
of amphiphysin I to lipid membrane was attenuated by 
Cdk5-dependent phosphorylation of wild-type amphi-
physin I,  but not of the S276,  285A form.  Endo-
cytosis was increased in rat PC12 cells expressing 
amphiphysin I S276,  285A in comparison with the 
wild type.  These results suggest that Ser276 and 
Ser285 are regulatory Cdk5 phosphosites of amphi-
physin I in the lipid-bound state.  Phosphorylation at 
these 2 sites alters binding of amphiphysin I to lipid 
membranes,  and may be an important r aspect of SVE 
regulation.
Amphiphysin I is Truncated by Calpain during 
Hyperexcitation and the Regulation in 
Synaptic Vesicle Endocytosis
　 Overloading of Ca2＋ in presynaptic terminals is 
observed in a host of neuronal diseases,  such as isch-
emia/anoxia,  epilepsy,  stroke,  trauma,  and Alzhei-
merʼs disease.  In these cases,  overactivation of Ca2＋
-dependent neutral protease calpain has been reported 
to induce neuronal damages by selective proteolysis of 
some target proteins,  including cytoskeletal proteins,  
membrane proteins,  and cytosolic proteins [see 
reviews 127-129].  The most recent work showed that 
amphiphysin I is truncated into 3 fragments detected 
by anti-amphiphysin I-N-terminal antibody in mice hip-
pocampal slices during the hyperexcitation induced by 
high potassium stimulation,  repetitive high-frequency 
stimulation and kainate-induced seizures [31].  Time-
dependent cleavages of amphiphysin I and α-spectrin,  
a physiological substrate of calpain,  in mice hippocam-
pal slices after high potassium stimulation showed 
similar time-dependent protein degradation patterns.  
In addition,  the truncations were inhibited by pre-
treatment with calpain inhibitors ALLM and ALLN.  
These data suggest that calpain is overactivated in the 
nerve terminal upon high potassium stimulation,  and 
that calpain is an in vivo protease for amphiphysin I.  
Consistently,  in vitro,  m-calpain cleaved amphiphysin 
I into 3 fragments corresponding to the truncations 
induced by high potassium stimulation in hippocampal 
slices.  The nine cleavage sites in amphiphysin I for 
m-calpain in vitro have been identiﬁed with mass spec-
trometry (MS) analysis; they are 333,  377,  392,  
454,  478,  527,  531,  593 and 609.  Three major 
cleavage sites,  333,  377 and 392,  are around the 
middle CLAP domain,  and the other sites are in the 
C terminus (Fig.  4A).  Amphiphysin I N-terminal 
recombinant proteins (1-333,  1-377 and 1-392) showed 
the same electrophoretic mobility to calpain-cleaved 
amphiphysin I fragments in vitro.  No C-terminal frag-
ments were detected with speciﬁc anti-amphiphysin 
I-C-terminal antibody in vivo or in vitro after calpain 
cleaved amphi physin I.  This suggests that amph-
iphysin I is truncated by calpain to N-terminal frag-
ments at multiple cleavage sites and loses its C termi-
nus during hyperexcitation (Fig.  4A).
　 Calpain has 2 isozymes (µ-calpain and m-calpain) in 
the brain.  µ-Calpain is activated at a micromolar Ca2＋,  
whereas m-calpain is activated at millimolar Ca2＋.  The 
relative abundance and localization of mRNAs for µ- 
and m-calpain in the brain were studied by using a 
combination of reverse transcriptase-polymerase chain 
reaction and in situ hybridization [130].  Expression 
of m-calpain mRNA was found to be 15-fold higher 
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than that of µ-calpain in whole-brain homogenates.  
µ-Calpain messages were observed to be diﬀused 
throughout the entire brain in both neurons and glia,  
whereas messages for m-calpain were localized to 
distinct neuronal populations,  including all cornu 
ammonis regions of the hippocampus,  cortical pyrami-
dal neurons,  and cerebellar Purkinje cells.  
Subcellular localization for both isozymes in hip-
pocampal neurons is not clear.  Both µ- and m-calpain 
were detected in the membrane and cytosolic fractions 
of puriﬁed synaptosomes (LP2 and LS2 fractions) 
[31].  In vitro,  µ-calpain can also induce amphiphysin 
I cleavages to the same 3 major truncated forms as 
m-calpain,  in addition to a new truncated form 
between the 52- and 47-kDa forms.  Considering the 
expression levels in neurons,  the Ca2＋ requirement 
for activity and the amphiphysin I truncation pattern,  
m-calpain is more like amphiphysin I in vivo protease 
upon neuronal hyperexcitation.
　 What will regulate calpain-dependent amphiphysin 
I cleavage: interaction with other partners or amphi-
physin Iʼs phosphorylation conditions? In vitro evidence 
317Amphiphysin I and Regulation of Synaptic Vesicle EndocytosisDecember 2009
Fig. 4　 Amphiphysin I (amphi.  I) is truncated by calpain during neural hyperexcitation.  A,  amphi.  I is cleaved by calpain to three 
N-terminal fragments (1-392,  1-377 and 1-333) during neural hyperexcitation at nine sites shown in the ﬁgure.  These three truncations 
contain the N-terminal BAR domain but do not have the C-terminal SH3 domain after calpain proteolysis,  thus blocking the association 
with dynamin 1 (dyn.  I),  although amphiphysin I can still bind with liposome by the BAR domain in vitro.  The defect in recruiting dyn.  I to 
the clathrin complex is suggested to inhibit clathrin-mediated SVE; B,  calpain-dependent truncation of amphiphysin I is regulated by 
interaction with other endocytic components,  such as lipid membrane and dyn.  I.  When nerve terminals are overloaded with Ca2＋,  calpain 
will be overactivated.  The overactivated calpain only proteolyzes free amphiphysin I,  including that in the phosphorylated or dephosphory-
lated form,  but not that in the clathrin complex-binding form.
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showed that the interaction with liposome or dynamin 
blocked amphiphysin I cleavage upon calpain proteoly-
sis,  but amphiphysin I phosphorylation status did not 
inﬂuence the cleavage directly.  In the presence of 
calcineurin inhibitor FK506,  the level of amphiphysin 
I cleavage was increased upon high potassium stimula-
tion in mice hippocampal slices.  These results suggest 
that the association of amphiphysin I with synaptic 
membranes and dynamin may be crucial for the regula-
tion of its cleavage by calpain.  They also suggest that 
phosphorylation of amphiphysin I does not directly 
inﬂuence the cleavage of amphiphysin I by calpain but 
rather inhibits the formation of a complex with endo-
cytic proteins and synaptic vesicle membranes,  result-
ing in the induction of amphiphysin I cleavage by cal-
pain during hyperexcitation (Fig.  4B) [31].
　 Functional analysis showed that the calpain-
induced truncated form of amphiphysin I (1-392) is 
capable of tubulation with liposomes but does not form 
ring structures with dynamin I in the solution or on 
lipid tubules in vitro.  Overexpression of the truncated 
form in Cos-7 cells and in hippocampal primary culture 
neurons showed signiﬁcant inhibition of transferrin 
uptake and synaptic vesicle endocytosis.  By now,  this 
picture emerges: When neuronal hyperexcitability is 
transferred to the nerve terminal,  a massive inﬂux of 
Ca2＋ reaches the nerve terminal,  and then amph-
iphysin I and the other endocytic dephosphins are 
dephosphorylated by Ca2＋-dependent phosphatase 
calcineurin and recruited to form a clathrin complex.  
On the other hand,  at the same time,  overloading of 
Ca2＋ in presynapses overactivates calpain activities.  
Free amphi physin I,  including the phosphorylated and 
dephosphorylated forms,  which are not yet recruited 
to the complex,  is quickly truncated to BAR domain-
containing N-terminal fragments by calpain 
(C-terminal SH3 domain is degraded).  The trunca-
tions block the interaction of amphiphysin I with 
dynamin I,  a key molecule in the ﬁssion of clathrin-
coated buds from presynaptic membranes by its 
GTPase activity.  In addition,  the N-terminal frag-
ments of amphiphysin I still retained the ability to bind 
to liposome membranes,  suggesting a dominant-nega-
tive eﬀect of amphiphysin I cleavage,  which will 
inhibit wild-type amphiphysin I from interacting with 
synaptic plasma membrane and thus will also inhibit 
the recruitment of its partners.  By these 2 inhibitory 
eﬀects,  calpain-dependent amphiphysin I truncations 
inhibit continuous clathrin-mediated SVE and thus may 
fail to sustain synaptic transmission during hyperexci-
tation [31].
　 But what is the physiological signiﬁcance of cal-
pain-dependent amhiphysin I truncations during neural 
hyperexcitation observed in neural diseases such as 
ischemia/anoxia,  epilepsy,  stroke,  and Alzheimerʼs 
disease? Repetitive high-frequency electrical stimula-
tion (HFS) or continuous high potassium stimulation-
induced postsynaptic short-term depression has been 
thought to be a neuronal auto-protective mechanism 
against neuroexcitotoxicity during neural hyperexcita-
tion.  Clathrin-mediated SVE,  a major pathway to 
maintain synaptic vesicle recycling during HFS,  is 
inhibited during HFS-induced short-term depression,  
suggesting a role for inhibited presynaptic vesicle 
endocytosis in the induction of postsynaptic short-term 
depression.  Calpain-dependent amphiphysin I trunca-
tion was observed during HFS-induced fEPSP (ﬁeld 
excitatory postsynaptic potential) depression at syn-
apses from Schaﬀer collaterals onto CA1 pyramidal 
neurons in mice hippocampal slices.  ALLM perfusion 
inhibited the HFS-induced fEPSP depression,  but had 
no eﬀect on the fEPSP slope when slices were stimu-
lated with LFS (low-frequency stimulation).  These 
ﬁndings suggest that calpain-dependent amphiphysin I 
truncations may be involved in HFS-induced short-
term depression,  the auto-protective mechanism dur-
ing neural hyperexcitation,  by inhibiting clathrin-
mediated SVE.  Further,  calpain-dependent 
amphiphysin I truncations are also observed in low- and 
high-dose kainate (KA)-induced seizures in FVB/NJ 
mice.  Preconditioning with low-dose KA reduced the 
development of seizures induced by high-dose KA.  
However,  pretreatment with ALLM attenuated the 
preconditioning eﬀect.  Taken together,  the in vivo and 
in vitro studies showed that hyperexcitation-induced 
amphiphysin I cleavage plays a role in protecting 
neurons from neuroexcitotoxicity during hyperexcita-
tion [31].
Summary
　 Acute interruption of amphiphysin I function in 
neurons showed that amphiphysin I plays an essential 
role in clathrin-mediated SVE by acting as a multi-
functional adaptor connecting various endocytic pro-
teins and endocytic machinery regulators to each other 
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or to the synaptic plasma membrane,  including clath-
rin,  AP2,  endophillin,  synaptojanin,  dynamin I,  cdk5 
/p35 complex,  PLD,  calcineurin-dynamin complex,  
and cain.  All these components are working coordi-
nately to sustain synaptic vesicle recycling during 
synaptic transmission.  But these initial pieces of evi-
dence for a role of amphiphysin I in synaptic vesicle 
recycling and endocytosis came from cell-based assays 
employing overexpression of dominant-negative con-
structs.  Is amphiphysin I really essential for synaptic 
vesicle recycling and endocytosis in the context of a 
whole animal? This is examined in amphiphysin 1 
(AMPH1) gene knockout mice [44].  Unexpectedly,  no 
apparent defects were found in nerve terminals of 
amphiphysin I knockout mice during resting condi-
tions.  Only under stimulated conditions,  amphiphysin 
I deﬁciency induced incomplete inhibition of synaptic 
vesicle endocytosis,  though amphiphysin I knockout 
brain cytosol showed defects in recruiting major endo-
cytic proteins (clathrin,  AP2 and synaptojanin) to 
liposomes as well as showing associations between 
dynamin PRD domain 1 and both clathrin and AP2 in 
vitro.  This suggests that amphiphysin Iʼs function in 
clathrin-mediated SVE may be partly compensated by 
other endocytic proteins when in the absence of amph-
iphysin I in vivo,  but this eﬀect may depend on the 
absence of amphiphysin I protein.  It is interesting that 
amphiphysin I knockout mice showed increased suscep-
tibility to seizures,  leading to reduced viability [44];  
this suggests that amphiphysin I,  as an important 
endocytic protein,  is involved in the prevention 
mechanism from neural hyperexcitation.  And amphi‒
physin Iʼs neural-protective role may be executed by 
calpain-dependent amphiphysin I truncation-induced 
SVE inhibition during hyperexcitation [31].  Amphi-
physin I knockout mice also showed learning deﬁcits,  
suggesting a critical role for amphiphysin in higher 
brain function [44].  Taken together,  the results 
indicate that amphiphysin I has a positive role in sus-
taining synaptic transmission not only under physiolog-
ical conditions,  but also under physiopathological 
conditions (hyperexcitation) by regulating clathrin-
mediated SVE.
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